SOURCE: American Diabetes Association

American Diabetes Association

American Diabetes Association

January 29, 2014 09:43 ET

American Diabetes Association, Lilly Announce New Scholars Program for 74th Annual Scientific Sessions

ALEXANDRIA, VA and INDIANAPOLIS, IN--(Marketwired - Jan 29, 2014) - The American Diabetes Association (Association) and Eli Lilly and Company are pleased to announce the creation of the American Diabetes Association Scholars Program. The program, made possible through $1.1 million in support from Lilly, will provide scholarships for up to 100 scholars from outside the U.S. to attend this year's Scientific Sessions, the world's largest scientific and medical conference focused on diabetes and its complications.

"The American Diabetes Association is thrilled to join with Eli Lilly and Company to award the American Diabetes Association Scholars Program," said Robert E. Ratner, MD, FACP, FACE, chief scientific & medical officer, American Diabetes Association. "Lilly's support provides scientists from countries around the world that are seeing a significant increase in diabetes, the opportunity to attend this educational program and be trained in the clinical management of the disease. Then, they will be able to return to their home country and conduct these educational programs, furthering our fight to Stop Diabetes® across the globe."

The Association's 74th Annual Scientific Sessions, to be held in San Francisco June 13-17, brings together physicians, scientists and other health care professionals from around the world to learn about the latest advances in basic and clinical science for diabetes. Selected scholars will attend the program, as well as participate in a professional education program which will provide training and resources for scholars to serve as faculty for professional education programs when they return to their home countries. The Association will provide reporting tools for scholars and track the presentation opportunities they undertake.

"Diabetes is a global epidemic, so it's critical that clinicians and scientists across the world have access to the most recent information in order to appropriately treat and fight this disease," said Robert Heine, vice president, medical affairs, Lilly Diabetes. "Lilly is pleased to provide support for the Association's scholars program and looks forward to this year's Scientific Sessions."

Countries participating in the program include:

  • Algeria
  • Argentina
  • Brazil
  • China
  • Colombia
  • Egypt
  • Ghana
  • India
  • Indonesia
  • Kenya
  • Malaysia
  • Mexico
  • Morocco
  • Nigeria
  • Philippines
  • Singapore
  • South Africa
  • Taiwan
  • Thailand
  • Vietnam

Interested applicants should email for more information.

To learn more about Lilly Diabetes, visit

About the American Diabetes Association
The American Diabetes Association is leading the fight to Stop Diabetes® and its deadly consequences and fighting for those affected by diabetes. The Association funds research to prevent, cure, and manage diabetes; delivers services to hundreds of communities; provides objective and credible information; and gives voice to those denied their rights because of diabetes. Founded in 1940, our mission is to prevent and cure diabetes and to improve the lives of all people affected by diabetes. For more information please call the American Diabetes Association at 1-800-DIABETES (1-800-342-2383) or visit Information from both these sources is available in English and Spanish.

About Lilly Diabetes
Lilly has been a global leader in diabetes care since 1923, when we introduced the world's first commercial insulin. Today we are building upon this heritage by working to meet the diverse needs of people with diabetes and those who care for them. Through research and collaboration, a broad and growing product portfolio and a continued determination to provide real solutions -- from medicines to support programs and more -- we strive to make life better for all those affected by diabetes around the world. For more information, visit

About Eli Lilly and Company
Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, IN, Lilly provides answers -- through medicines and information -- for some of the world's most urgent medical needs. Additional information about Lilly is available at

Contact Information


Keyword Cloud

View Website